These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 32546566)

  • 1.
    Roston A; Evans D; Gill H; McKinnon M; Isidor B; Cogné B; Mwenifumbo J; van Karnebeek C; An J; Jones SJM; Farrer M; Demos M; Connolly M; Gibson WT; ;
    J Med Genet; 2021 Mar; 58(3):196-204. PubMed ID: 32546566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo variants in SETD1B are associated with intellectual disability, epilepsy and autism.
    Hiraide T; Nakashima M; Yamoto K; Fukuda T; Kato M; Ikeda H; Sugie Y; Aoto K; Kaname T; Nakabayashi K; Ogata T; Matsumoto N; Saitsu H
    Hum Genet; 2018 Jan; 137(1):95-104. PubMed ID: 29322246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delineating the molecular and phenotypic spectrum of the SETD1B-related syndrome.
    Weerts MJA; Lanko K; Guzmán-Vega FJ; Jackson A; Ramakrishnan R; Cardona-Londoño KJ; Peña-Guerra KA; van Bever Y; van Paassen BW; Kievit A; van Slegtenhorst M; Allen NM; Kehoe CM; Robinson HK; Pang L; Banu SH; Zaman M; Efthymiou S; Houlden H; Järvelä I; Lauronen L; Määttä T; Schrauwen I; Leal SM; Ruivenkamp CAL; Barge-Schaapveld DQCM; Peeters-Scholte CMPCD; Galehdari H; Mazaheri N; Sisodiya SM; Harrison V; Sun A; Thies J; Pedroza LA; Lara-Taranchenko Y; Chinn IK; Lupski JR; Garza-Flores A; McGlothlin J; Yang L; Huang S; Wang X; Jewett T; Rosso G; Lin X; Mohammed S; Merritt JL; Mirzaa GM; Timms AE; Scheck J; Elting MW; Polstra AM; Schenck L; Ruzhnikov MRZ; Vetro A; Montomoli M; Guerrini R; Koboldt DC; Mosher TM; Pastore MT; McBride KL; Peng J; Pan Z; Willemsen M; Koning S; Turnpenny PD; de Vries BBA; Gilissen C; Pfundt R; Lees M; Braddock SR; Klemp KC; Vansenne F; van Gijn ME; Quindipan C; Deardorff MA; Hamm JA; Putnam AM; Baud R; Walsh L; Lynch SA; Baptista J; Person RE; Monaghan KG; Crunk A; Keller-Ramey J; Reich A; Elloumi HZ; Alders M; Kerkhof J; McConkey H; Haghshenas S; ; Maroofian R; Sadikovic B; Banka S; Arold ST; Barakat TS
    Genet Med; 2021 Nov; 23(11):2122-2137. PubMed ID: 34345025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connectome Analysis in an Individual with SETD1B -Related Neurodevelopmental Disorder and Epilepsy.
    Weng R; Nenning KH; Schwarz M; Riedhammer KM; Brunet T; Wagner M; Kasprian G; Lehrner J; Zimprich F; Bonelli SB; Krenn M
    J Dev Behav Pediatr; 2022 Aug; 43(6):e419-e422. PubMed ID: 35385430
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Hubert L; Cannata Serio M; Villoing-Gaudé L; Boddaert N; Kaminska A; Rio M; Lyonnet S; Munnich A; Poirier K; Simons M; Besmond C
    J Med Genet; 2020 Feb; 57(2):138-144. PubMed ID: 31439720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deleterious Variation in BRSK2 Associates with a Neurodevelopmental Disorder.
    Hiatt SM; Thompson ML; Prokop JW; Lawlor JMJ; Gray DE; Bebin EM; Rinne T; Kempers M; Pfundt R; van Bon BW; Mignot C; Nava C; Depienne C; Kalsner L; Rauch A; Joset P; Bachmann-Gagescu R; Wentzensen IM; McWalter K; Cooper GM
    Am J Hum Genet; 2019 Apr; 104(4):701-708. PubMed ID: 30879638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An atypical 12q24.31 microdeletion implicates six genes including a histone demethylase KDM2B and a histone methyltransferase SETD1B in syndromic intellectual disability.
    Labonne JD; Lee KH; Iwase S; Kong IK; Diamond MP; Layman LC; Kim CH; Kim HG
    Hum Genet; 2016 Jul; 135(7):757-71. PubMed ID: 27106595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterozygous variants in SPTBN1 cause intellectual disability and autism.
    Rosenfeld JA; Xiao R; Bekheirnia MR; Kanani F; Parker MJ; Koenig MK; van Haeringen A; Ruivenkamp C; Rosmaninho-Salgado J; Almeida PM; Sá J; Pinto Basto J; Palen E; Oetjens KF; Burrage LC; Xia F; Liu P; Eng CM; ; Yang Y; Posey JE; Lee BH
    Am J Med Genet A; 2021 Jul; 185(7):2037-2045. PubMed ID: 33847457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo heterozygous missense and loss-of-function variants in CDC42BPB are associated with a neurodevelopmental phenotype.
    Chilton I; Okur V; Vitiello G; Selicorni A; Mariani M; Goldenberg A; Husson T; Campion D; Lichtenbelt KD; van Gassen K; Steinraths M; Rice J; Roeder ER; Littlejohn RO; Srour M; Sebire G; Accogli A; Héron D; Heide S; Nava C; Depienne C; Larson A; Niyazov D; Azage M; Hoganson G; Burton J; Rush ET; Jenkins JL; Saunders CJ; Thiffault I; Alaimo JT; Fleischer J; Groepper D; Gripp KW; Chung WK
    Am J Med Genet A; 2020 May; 182(5):962-973. PubMed ID: 32031333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of exome sequencing in individuals with large homozygous regions detected by chromosomal microarray analysis.
    Prasad A; Sdano MA; Vanzo RJ; Mowery-Rushton PA; Serrano MA; Hensel CH; Wassman ER
    BMC Med Genet; 2018 Mar; 19(1):46. PubMed ID: 29554876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and genetic analysis of six Chinese children with Poirier-Bienvenu neurodevelopmental syndrome caused by CSNK2B mutation.
    Yang S; Wu L; Liao H; Lu X; Zhang X; Kuang X; Yang L
    Neurogenetics; 2021 Oct; 22(4):323-332. PubMed ID: 34370157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic variants in
    Granadillo JL; P A Stegmann A; Guo H; Xia K; Angle B; Bontempo K; Ranells JD; Newkirk P; Costin C; Viront J; Stumpel CT; Sinnema M; Panis B; Pfundt R; Krapels IPC; Klaassens M; Nicolai J; Li J; Jiang Y; Marco E; Canton A; Latronico AC; Montenegro L; Leheup B; Bonnet C; M Amudhavalli S; Lawson CE; McWalter K; Telegrafi A; Pearson R; Kvarnung M; Wang X; Bi W; Rosenfeld JA; Shinawi M
    J Med Genet; 2020 Oct; 57(10):717-724. PubMed ID: 32152250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variants in GNAI1 cause a syndrome associated with variable features including developmental delay, seizures, and hypotonia.
    Muir AM; Gardner JF; van Jaarsveld RH; de Lange IM; van der Smagt JJ; Wilson GN; Dubbs H; Goldberg EM; Zitano L; Bupp C; Martinez J; Srour M; Accogli A; Alhakeem A; Meltzer M; Gropman A; Brewer C; Caswell RC; Montgomery T; McKenna C; McKee S; Powell C; Vasudevan PC; Brady AF; Joss S; Tysoe C; Noh G; Tarnopolsky M; Brady L; Zafar M; Schrier Vergano SA; Murray B; Sawyer L; Hainline BE; Sapp K; DeMarzo D; Huismann DJ; Wentzensen IM; Schnur RE; Monaghan KG; Juusola J; Rhodes L; Dobyns WB; Lecoquierre F; Goldenberg A; Polster T; Axer-Schaefer S; Platzer K; Klöckner C; Hoffman TL; MacArthur DG; O'Leary MC; VanNoy GE; England E; Varghese VC; Mefford HC
    Genet Med; 2021 May; 23(5):881-887. PubMed ID: 33473207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recessive variants in ZNF142 cause a complex neurodevelopmental disorder with intellectual disability, speech impairment, seizures, and dystonia.
    Khan K; Zech M; Morgan AT; Amor DJ; Skorvanek M; Khan TN; Hildebrand MS; Jackson VE; Scerri TS; Coleman M; Rigbye KA; Scheffer IE; Bahlo M; Wagner M; Lam DD; Berutti R; Havránková P; Fečíková A; Strom TM; Han V; Dosekova P; Gdovinova Z; Laccone F; Jameel M; Mooney MR; Baig SM; Jech R; Davis EE; Katsanis N; Winkelmann J
    Genet Med; 2019 Nov; 21(11):2532-2542. PubMed ID: 31036918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic yield of genetic and metabolic investigations in syndromic and nonsyndromic patients with autism spectrum disorder, global developmental delay, or intellectual disability from a dedicated neurodevelopmental disorders genetics clinic.
    Postma JK; Harrison MA; Kutcher S; Webster RJ; Cloutier M; Bourque DK; Yu AC; Carter MT
    Am J Med Genet A; 2024 Nov; 194(11):e63791. PubMed ID: 39031819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare predicted deleterious FEZF2 variants are associated with a neurodevelopmental phenotype.
    Garber A; Weingarten LS; Abreu NJ; Elloumi HZ; Haack T; Hildebrant C; Martínez-Gil N; Mathews J; Müller AJ; Valenzuela Palafoll I; Steigerwald C; Chung WK
    Am J Med Genet A; 2024 Jul; 194(7):e63578. PubMed ID: 38425142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel de novo frameshift variant in SETD1B causes epilepsy.
    Den K; Kato M; Yamaguchi T; Miyatake S; Takata A; Mizuguchi T; Miyake N; Mitsuhashi S; Matsumoto N
    J Hum Genet; 2019 Aug; 64(8):821-827. PubMed ID: 31110234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo mutations in HNRNPU result in a neurodevelopmental syndrome.
    Yates TM; Vasudevan PC; Chandler KE; Donnelly DE; Stark Z; Sadedin S; Willoughby J; ; ; Balasubramanian M
    Am J Med Genet A; 2017 Nov; 173(11):3003-3012. PubMed ID: 28944577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exome sequencing analysis in a pair of monozygotic twins re-evaluates the genetics behind their intellectual disability and reveals a CHD2 mutation.
    Pinto AM; Bianciardi L; Mencarelli MA; Imperatore V; Di Marco C; Furini S; Suppiej A; Salviati L; Tenconi R; Ariani F; Mari F; Renieri A
    Brain Dev; 2016 Jun; 38(6):590-6. PubMed ID: 26754451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo missense variants in HDAC3 leading to epigenetic machinery dysfunction are associated with a variable neurodevelopmental disorder.
    Yoon JG; Lim SK; Seo H; Lee S; Cho J; Kim SY; Koh HY; Poduri AH; Ramakumaran V; Vasudevan P; de Groot MJ; Ko JM; Han D; Chae JH; Lee CH
    Am J Hum Genet; 2024 Aug; 111(8):1588-1604. PubMed ID: 39047730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.